Detalhe da pesquisa
1.
Psychosocial impact of the COVID-19 pandemic on patients with inflammatory bowel disease in Spain. A post lockdown reflection.
Gastroenterol Hepatol
; 45(9): 668-676, 2022 Nov.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-34562522
2.
Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry.
Dig Dis Sci
; 66(6): 2014-2023, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32671587
3.
Serum and Urine Metabolomic Profiling of Newly Diagnosed Treatment-Naïve Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis
; 30(2): 167-182, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536268
4.
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry.
Therap Adv Gastroenterol
; 17: 17562848231221713, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38187926
5.
Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry.
Dig Liver Dis
; 55(1): 46-52, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948459
6.
Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA Registry.
J Crohns Colitis
; 16(6): 946-953, 2022 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34864947
7.
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients.
Front Med (Lausanne)
; 9: 823900, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35178413
8.
Preferences and satisfaction of IBD patients after switching from adalimumab 40 mg weekly to 80 mg every other week given as a single injection: the ADASCAL study.
Therap Adv Gastroenterol
; 14: 17562848211056157, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35116079
9.
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry.
J Crohns Colitis
; 15(11): 1846-1851, 2021 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33860795
10.
Effects of anti-TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease.
Dig Liver Dis
; 52(4): 400-407, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31892506
11.
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Inflamm Bowel Dis
; 26(4): 606-616, 2020 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504569
12.
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.
Therap Adv Gastroenterol
; 12: 1756284819847034, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31205485
13.
Fecal calprotectin is not superior to serum C-reactive protein or the Harvey-Bradshaw index in predicting postoperative endoscopic recurrence in Crohn's disease.
Eur J Gastroenterol Hepatol
; 30(12): 1521-1527, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30303822
14.
Short and long-term effectiveness and safety of vedolizumab in inflammatory bowel disease: results from the ENEIDA registry.
Aliment Pharmacol Ther
; 48(8): 839-851, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30281832
15.
Anemia at the time of diagnosis of inflammatory bowel disease: Prevalence and associated factors in adolescent and adult patients.
Dig Liver Dis
; 49(4): 405-411, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28096058
16.
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
Inflamm Bowel Dis
; 22(4): 894-901, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26933750
17.
Epidemiology and temporal trends (2000-2012) of inflammatory bowel disease in adult patients in a central region of Spain.
Eur J Gastroenterol Hepatol
; 26(12): 1399-407, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341061